Eterna Therapeutics Inc. (NASDAQ:ERNA) Short Interest Update

Eterna Therapeutics Inc. (NASDAQ:ERNA) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 115,000 shares, an increase of 142.6% from the November 15th total of 47,400 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 653,700 shares, the days-to-cover ratio is currently 0.2 days.

Eterna Therapeutics Trading Down 0.3 %

Shares of ERNA stock traded down $0.00 during mid-day trading on Friday, reaching $0.29. The stock had a trading volume of 295,583 shares, compared to its average volume of 187,239. Eterna Therapeutics has a 12-month low of $0.27 and a 12-month high of $2.63. The business has a 50-day simple moving average of $0.81 and a 200 day simple moving average of $1.42.

About Eterna Therapeutics

Eterna Therapeutics Inc, a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited.